<p>Martine A. Rothblatt, Chairperson and CEO of United Therapeutics Corporation, reported a disposal of common shares of United Therapeutics Corporation. The full filing can be accessed through the link below. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. United Therapeutics Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001106578-25-000042), on December 19, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT) Original Document: here</p>

UTHR

<p>Martine A. Rothblatt, CEO of United Therapeutics, reported the disposal of common shares of the company. The filing is available via EDGAR, the SEC's system. This AI-generated news is for informational purposes and not financial advice.</p>

United Therapeutics Chairperson and CEO Martine A. Rothblatt reports disposal of common shares